Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Mismatch Repair01:20

Mismatch Repair

4.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

6.9K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
6.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same author

An orally active dual CBP/p300 degrader targets core dependencies of multiple myeloma.

Cell reports·2026
Same author

ATM counteracts chromatin-bound cGAS during DNA replication.

Nature cell biology·2026
Same author

BRCA1-A and LIG4 complexes mediate ecDNA biogenesis and cancer drug resistance.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Targeted therapy-induced chromosomal instability dictates mitotic dependency on Aurora Kinase A.

bioRxiv : the preprint server for biology·2026
Same author

ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription Reprogramming.

The Journal of clinical investigation·2026

Related Experiment Video

Updated: May 15, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.0K

Gap resection matters in BRCA mutant cancer.

Lee Zou1

  • 1Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710, USA lee.zou@duke.edu.

Genes & Development
|April 10, 2025
PubMed
Summary

BRCA1 deficiency causes persistent DNA gaps in cancer cells treated with PARP inhibitors (PARPis). These gaps lead to DNA double-stranded breaks (DSBs) during replication, explaining PARPi sensitivity in BRCA-mutant tumors.

Keywords:
BRCADNA replicationDNA replication stressMRE11PARP inhibitorgenome stabilitynucleasessingle-stranded DNA gaps

More Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

14.6K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.2K

Related Experiment Videos

Last Updated: May 15, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.0K
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

14.6K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.2K

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • BRCA1/2-deficient cancer cells exhibit DNA repair defects, conferring sensitivity to Poly (ADP-ribose) polymerase inhibitors (PARPis).
  • Understanding the precise mechanisms underlying this sensitivity is crucial for targeted cancer therapy.

Purpose of the Study:

  • To investigate the role of BRCA1 in protecting single-stranded DNA gaps from nucleolytic degradation.
  • To elucidate the cellular events leading to DNA double-stranded breaks (DSBs) in BRCA1-deficient cells upon PARPi treatment.

Main Methods:

  • Utilized cell-based assays to track DNA gap formation and processing.
  • Employed techniques to analyze exonuclease activity and DNA repair pathways.
  • Investigated cell cycle-dependent DNA damage responses.

Main Results:

  • PARPi treatment induces DNA gaps that are rapidly resected by exonucleases and filled by translesion synthesis.
  • BRCA1-deficient cells display excessive gap resection, leading to persistent and enlarged single-stranded DNA gaps.
  • These gaps induce DSBs through replication fork collisions in a cell cycle-dependent manner, rather than direct endonuclease activity.

Conclusions:

  • BRCA1 plays a critical role in limiting DNA gap resection, thereby preventing the accumulation of DNA damage.
  • The excessive resection of DNA gaps in BRCA1-deficient cells is a key mechanism driving DSB formation and PARPi sensitivity.
  • This study provides a detailed molecular explanation for how BRCA1 loss contributes to the efficacy of PARP inhibitors in BRCA-mutant cancers.